generative biology trends
Is Generative Biology Trends Pharma's Salvation?
Yes, generative biology trends, which are already tackling a 90% failure rate, are poised to become pharma's salvation. By leveraging compute-driven protein folding, companies can move from months-long trial-and-error to days of in-silico prediction, reshaping the economics of drug development. Medical Disclaimer: This article is for informational purposes